Shares of Arecor Therapeutics plc (LON:AREC – Get Free Report) fell 7.8% during mid-day trading on Friday . The stock traded as low as GBX 64.50 ($0.81) and last traded at GBX 70.50 ($0.89). 18,864 shares were traded during trading, an increase of 37% from the average session volume of 13,806 shares. The stock had previously closed at GBX 76.50 ($0.97).
Arecor Therapeutics Price Performance
The stock has a 50-day simple moving average of GBX 74.06 and a 200 day simple moving average of GBX 91.08. The company has a market cap of £26.62 million, a PE ratio of -251.79 and a beta of -0.18. The company has a quick ratio of 6.24, a current ratio of 1.37 and a debt-to-equity ratio of 5.51.
About Arecor Therapeutics
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
See Also
- Five stocks we like better than Arecor Therapeutics
- What is MarketRank™? How to Use it
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- How to Calculate Inflation Rate
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
